title: [Additional possibilities for correction of movement disorders induced by neuroleptics in patients with schizophrenia].
authors.forename: D G
authors.initials: DG
authors.lastname: Semenikhin
authors.forename: A V
authors.initials: AV
authors.lastname: Kuchaeva
authors.forename: A M
authors.initials: AM
authors.lastname: Karpov
authors.forename: E B
authors.initials: EB
authors.lastname: Mikhaĭlova
authors.forename: A V
authors.initials: AV
authors.lastname: Murav'eva
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology*; D010455:Peptides / Q000627:therapeutic use*; D011788:Quality of Life; D012563:Schizophrenia, Paranoid / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C056590:cortexin